Christopher Richard Parish
21Patents
7h-index
32Co-inventors
69Inventor score
Filing activity: Mar 16, 1992 → Feb 6, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5677181A | Angiogenesis inhibitory antibodies | Chemistry; Metallurgy | 85 | Expired |
| US6143730A | Preparation and use of sulfated oligosaccharides | Chemistry; Metallurgy | 42 | Expired |
| US5874081A | Therapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesis | Chemistry; Metallurgy | 36 | Expired |
| US5541166A | Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity | Human Necessities | 20 | Expired |
| US5506210A | Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs | Chemistry; Metallurgy | 10 | Expired |
| US6271215A | Sulfated oligosaccharides having anticoagulant/antithrombotic activity | Human Necessities | 8 | Expired |
| US6638916B1 | Use of sulfated oligosaccharides as inhibitors of cardiovascular disease | Human Necessities | 7 | Expired |
| US6242238A | Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor | Human Necessities | 7 | Expired |
| US5976782A | In-vitro angiogenesis assay | Physics | 6 | Expired |
| US6207402A | Detection of mammalian heparanase activity and purification of mammalian heparanase | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5837709A | Use of castanospermine as an anti-inflammatory and immunosupressant agent | Human Necessities | 2 | Expired |
| US9226939B2 | Histone inhibition | Human Necessities | 1 | Active |
| US5691346A | Castanospermine as an anti-inflammatory and immunosuppressant agent | Human Necessities | 1 | Expired |
| US6352852B1 | Method for the purification of human platelet heparanase | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7173019B2 | Linked cyclitols and their polysulfated derivatives | Chemistry; Metallurgy | 0 | Expired |
| US12295966B2 | Compounds for treating and preventing extracellular histone mediated pathologies | Human Necessities | 0 | Active |
| US8779107B2 | Composition for targeting dendritic cells | Chemistry; Metallurgy | 0 | Active |
| US10507236B2 | Chimeric proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US11628179B2 | Compounds for treating and preventing extracellular histone mediated pathologies | Human Necessities | 0 | Active |
| US6670339B1 | Use of sulfated oligosaccharides in lowering blood triglyceride levels | Human Necessities | 0 | Expired |
| US12239650B2 | Compounds for treating and preventing net associated complications | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.